Individualizing dose and fractionation of radiotherapy is associated with excellent tumor control while minimizing adverse effects in treating patients’ lung cancer.
This is the conclusion of a paper published in JAMA Oncology from my time at Stanford.
I was able to contribute a small part to the overall endeavour.
I contributed a very small portion Congratulations to Dr. Michael Gensheimer, and Stanford Radiation Oncology!